These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

981 related items for PubMed ID: 15193408

  • 1. Can oral cholera vaccination play a role in controlling a cholera outbreak?
    Calain P, Chaine JP, Johnson E, Hawley ML, O'Leary MJ, Oshitani H, Chaignat CL.
    Vaccine; 2004 Jun 23; 22(19):2444-51. PubMed ID: 15193408
    [Abstract] [Full Text] [Related]

  • 2. [Cholera update and vaccination problems].
    Fournier JM, Villeneuve S.
    Med Trop (Mars); 1998 Jun 23; 58(2 Suppl):32-5. PubMed ID: 9812307
    [Abstract] [Full Text] [Related]

  • 3. Feasibility of mass vaccination campaign with oral cholera vaccines in response to an outbreak in Guinea.
    Ciglenecki I, Sakoba K, Luquero FJ, Heile M, Itama C, Mengel M, Grais RF, Verhoustraeten F, Legros D.
    PLoS Med; 2013 Jun 23; 10(9):e1001512. PubMed ID: 24058301
    [No Abstract] [Full Text] [Related]

  • 4. A cost-benefit analysis of programmatic use of CVD 103-HgR live oral cholera vaccine in a high-risk population.
    Cookson ST, Stamboulian D, Demonte J, Quero L, Martinez de Arquiza C, Aleman A, Lepetic A, Levine MM.
    Int J Epidemiol; 1997 Feb 23; 26(1):212-9. PubMed ID: 9126522
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR.
    Viret JF, Dietrich G, Favre D.
    Vaccine; 2004 Jun 23; 22(19):2457-69. PubMed ID: 15193410
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Potential impact of reactive vaccination in controlling cholera outbreaks: an exploratory analysis using a Zimbabwean experience.
    Kim SY, Choi Y, Mason PR, Rusakaniko S, Goldie SJ.
    S Afr Med J; 2011 Sep 05; 101(9):659-64. PubMed ID: 21920160
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.
    Khatib AM, Ali M, von Seidlein L, Kim DR, Hashim R, Reyburn R, Ley B, Thriemer K, Enwere G, Hutubessy R, Aguado MT, Kieny MP, Lopez AL, Wierzba TF, Ali SM, Saleh AA, Mukhopadhyay AK, Clemens J, Jiddawi MS, Deen J.
    Lancet Infect Dis; 2012 Nov 05; 12(11):837-44. PubMed ID: 22954655
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Oral vaccines against cholera.
    Shin S, Desai SN, Sah BK, Clemens JD.
    Clin Infect Dis; 2011 Jun 05; 52(11):1343-9. PubMed ID: 21498389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.